[ad_1]
The FHI calculations are regularly updated and the latest version was released on Tuesday afternoon.
Vaccine deliveries from Pfizer, Moderna, Janssen and AstraZeneca are included in the calculations.
Vaccination with the latest corona vaccine is still on hold, at the moment until April 12.
– aggravate the situation
Make changes
There are few changes that can be traced to the latest edition of the FHI progress plan for vaccination in Norway.
In the previous version of the vaccination progress plan in Norway, published on March 12, FHI calculated that all people in the 18-44 age group could have been offered the first dose by the end of June in its optimistic scenario, while the more sober noted in early July.
Therefore, the new progress plan has adjusted this a little more in time, until mid-July. This applies to both the optimistic and the more sober scenarios.
– So I realized that it was crown
– We probably think this scenario is quite likely. Of course, it depends on the doses of vaccine that were agreed to deliver on time, but there is no reason to believe there will be delays with that in mind now, infection control director Geir Bukholm at FHI tells Dagbladet.
– Will the vaccination also go faster?
“I think maybe the scenario that we have now is quite realistic, and much faster I think it is not very likely,” he says.
Norway lags behind the Nordic countries
Greater security
How quickly vaccines can be offered to different population groups depends on deliveries to Norway and which vaccines are approved for use.
Jasper Littmann, deputy director of the coronary vaccination program, told NTB that the reason the two scenarios, both the optimistic and the more sober, are similar in the new version, is that there is now greater certainty regarding the delivery time. of the different vaccines.
– Pfizer is the largest supplier and they have delivered steadily as of late, and they have also increased deliveries, so of course there may be more increases, says Bukholm.
MORE SIMILARITY: The deputy director of the coronary vaccination program at NIPH, Jasper Littmann, says there is now less uncertainty associated with delivery times for vaccines in use in Norway. This means that the optimistic and the most sober forecasts are more similar. Photo: Lise Åserud / NTB
see more
Today, the Pfizer / Biontech and Moderna vaccines are in active use in Norway, while the first doses of newcomer Janssen are expected in April.
– On stage, AstraZeneca is supposed to be used again. But that does not mean that we have concluded the case. That can change. When we had to update the scenario again, Littmann tells NTB.
Here are the new FHI calculations (March 12 calculations in parentheses):
- Health personnel: third week of May (third week of April)
- 75-84 years: third week of March (third week of March)
- 65-74 years + 18-64 years at high risk: third week of April (mid-April)
- 55-64 years, underlying disease: third week of April (mid-April)
- 45 to 54 years, underlying disease: third week of April (third week of April)
- 18 to 44 years, underlying disease: change of month April / May (change of month April / May)
- 55 to 64 years: mid-May (mid-May)
- 45-54 years: second week of June (second week of June)
- 18 to 44 years: second week of July (first week of July)
- The vast majority of nursing home residents and people over the age of 85 have already been fully vaccinated or have received the first dose of the vaccine.
